Lv22
150 积分 2021-02-24 加入
Identifying the genomic landscape of EGFR-mutant lung cancers with CNS metastases
3小时前
已完结
Osimertinib combined with anlotinib as first-line treatment in advanced or metastatic NSCLC patients with EGFR mutation: a prospective, single arm, exploratory study
1天前
求助中
Perioperative Safety and Efficacy of Efgartigimod for Thymoma associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial
8天前
已完结
Brief Report: The Immune Profiles of the Molecular Subtypes of EGFR-Mutant Lung Adenocarcinomas in a Large Real-World Cohort
6个月前
已完结
Timeliness of EGFR/ALK inhibitor treatment and survival in lung cancer: A population-based analysis
6个月前
已完结
SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma
7个月前
已完结
Loss of CDKN2A Enhances the Efficacy of Immunotherapy in EGFR Mutant Non-Small Cell Lung Cancer
7个月前
已完结
Transcriptomic heterogeneity of EGFR-mutant non-small cell lung cancer evolution towards small cell lung cancer
8个月前
已完结
Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis
8个月前
已完结
Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis
8个月前
已关闭
皖公网安备34019202002308
